Bone Biologics Corp (NASDAQ: BBLG)
$1.2700
+0.0200 ( +1.60% ) 0.3K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.2700
Previous close
$1.2500
Volume
0.3K
Market cap
$3.08M
Day range
$1.2500 - $1.2500
52 week range
$0.8000 - $10.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 57 | Nov 14, 2024 |
8-k | 8K-related | 16 | Oct 21, 2024 |
3 | Insider transactions | 1 | Oct 18, 2024 |
4 | Insider transactions | 1 | Oct 18, 2024 |
8-k | 8K-related | 14 | Oct 04, 2024 |
8-k | 8K-related | 18 | Sep 27, 2024 |
8-k | 8K-related | 14 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |